Back to top

Matinas BioPharma Ends At-The-Market Sales Agreement

Matinas BioPharma ( ($MTNB) ) has provided an announcement. Matinas BioPharma Holdings, Inc., a biopharmaceutical company that raises capital throu...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Matinas Biopharma Holdings, Inc. (MTNB)